Ying J - Search Results

1

Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers.

Ying J, Yang L, Yin JC, Xia G, Xing M, Chen X, Pang J, Wu Y, Bao H, Wu X, Shao Y, Zhu L, Cheng X. Ying J, et al. J Immunother Cancer. 2021 Sep;9(9):e002336. doi: 10.1136/jitc-2021-002336. J Immunother Cancer. 2021. PMID: 34479923 Free PMC article.

2

[Significance of multidrug resistance gene-associated proteins in the postoperative adjuvant chemotherapy for gastric carcinoma and the prognosis].

Yu PF, Guo JM, Xu Q, Ying JE, Wang XJ, Cheng XD, Wang XB, Yu CD. Yu PF, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2010 Apr;13(4):289-93. Zhonghua Wei Chang Wai Ke Za Zhi. 2010. PMID: 20422488 Chinese.

3

Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response.

Li J, Wei Q, Wu X, Sima J, Xu Q, Wu M, Wang F, Mou H, Hu H, Zhao J, Li D, Hu J, Zhang L, Zhu X, Chen L, Luo C, Yan J, He J, Ma Y, Shao Y, Wu W, Ying J. Li J, et al. Among authors: ying j. Clin Transl Med. 2020 Aug;10(4):e118. doi: 10.1002/ctm2.118. Clin Transl Med. 2020. PMID: 32898339 Free PMC article.

4

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.

Cheng X, Wu D, Xu N, Chen L, Yan Z, Chen P, Zhou L, Yu J, Cui J, Li W, Wang C, Feng W, Wei Y, Yu P, Du Y, Ying J, Xu Z, Yang L, Zhang Y. Cheng X, et al. Among authors: ying j. BMC Cancer. 2021 Jan 12;21(1):56. doi: 10.1186/s12885-020-07772-7. BMC Cancer. 2021. PMID: 33435909 Free PMC article.

5

Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial.

Zhang B, Huang J, Tang J, Hu S, Luo S, Luo Z, Zhou F, Tan S, Ying J, Chang Q, Zhang R, Geng C, Wu D, Gu X, Liu B. Zhang B, et al. Among authors: ying j. J Immunother Cancer. 2021 Apr;9(4):e002224. doi: 10.1136/jitc-2020-002224. J Immunother Cancer. 2021. PMID: 33837053 Free PMC article. Clinical Trial.

6

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes.

Chen X, Wang D, Liu J, Qiu J, Zhou J, Ying J, Shi Y, Wang Z, Lou H, Cui J, Zhang J, Liu Y, Zhao F, Pan L, Zhao J, Zhu D, Chen S, Li X, Li X, Zhu L, Shao Y, Shu Y. Chen X, et al. Among authors: ying j. J Immunother Cancer. 2021 Nov;9(11):e003214. doi: 10.1136/jitc-2021-003214. J Immunother Cancer. 2021. PMID: 34795005 Free PMC article.

7

Trametes robiniophila Murr Sensitizes Gastric Cancer Cells to 5-Fluorouracil by Modulating Tumor Microenvironment.

Xu JL, Yuan L, Hu C, Weng CY, Xu HD, Shi YF, Huang L, Ying JE, Xu ZY, Qin JJ, Cheng XD. Xu JL, et al. Front Pharmacol. 2022 May 17;13:911663. doi: 10.3389/fphar.2022.911663. eCollection 2022. Front Pharmacol. 2022. PMID: 35656301 Free PMC article.

8

Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapy.

Xu Q, Xu X, Tang H, Yan J, Li J, Bao H, Wu X, Shao Y, Luo C, Wen H, Jin J, Ying J. Xu Q, et al. Among authors: ying j. Oncogenesis. 2023 Apr 18;12(1):21. doi: 10.1038/s41389-023-00466-2. Oncogenesis. 2023. PMID: 37072406 Free PMC article.

9

Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration.

Wei Q, Yang T, Zhu J, Zhang Z, Yang L, Zhang Y, Hu C, Chen J, Wang J, Tian X, Shimura T, Fang J, Ying J, Fan M, Guo P, Cheng X. Wei Q, et al. Among authors: ying j. Clin Cancer Res. 2024 Mar 1;30(5):984-997. doi: 10.1158/1078-0432.CCR-23-1725. Clin Cancer Res. 2024. PMID: 38113039

10

The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors.

Wei Q, Li P, Yang T, Zhu J, Sun L, Zhang Z, Wang L, Tian X, Chen J, Hu C, Xue J, Ma L, Shimura T, Fang J, Ying J, Guo P, Cheng X. Wei Q, et al. Among authors: ying j. J Hematol Oncol. 2024 Jan 4;17(1):1. doi: 10.1186/s13045-023-01509-2. J Hematol Oncol. 2024. PMID: 38178200 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,140 results

Search Page

Filters